KVUE Earnings Date: Feb 16, 2027 (Estimated) — Kenvue Inc.
NYSE · Consumer Staples · Household & Personal Products
Updated
When is KVUE's next earnings date?
Kenvue Inc. (KVUE) is expected to report Q4 2026 earnings on Tuesday, February 16, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.27 on revenue of $3.87B.
How did KVUE do in its last earnings report?
In its most recent report on Oct 30, 2026 (Q3 2026), Kenvue Inc. posted EPS of $0.29 versus the $0.29 estimate, a miss of 0.6%. Revenue was $3.89B against a $3.86B estimate.
How much does KVUE stock move after earnings?
KVUE beat EPS estimates in 5 of its last 8 reported quarters. Over the last 7 reports the stock moved an average of 3.7% (up or down) in the day after earnings.
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
🤖 AI Earnings Analysis
Kenvue’s consumer-health and personal-care business delivered a modest revenue beat, with sales up 2.6% year over year to $3.9B, but EPS was merely in line at $0.29. Results are mixed: brand investment and savings support growth, while inflation and cautious spending pressure margins.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-30 | Q3 2026 | 0.29 | 0.29 | -0.62% | $3.89B | ❌ Miss | — | — | — |
| 2026-08-06 | Q2 2026 | 0.32 | 0.31 | -3.12% | $3.96B | ❌ Miss | -2.50% | -2.39% | -2.55% |
| 2026-05-07 | Q1 2026 | 0.26 | 0.32 | +23.08% | $3.91B | ✅ Beat | +0.23% | -1.58% | +1.41% |
| 2026-02-17 | Q4 2025 | 0.22 | 0.27 | +22.73% | $3.78B | ✅ Beat | +2.53% | +3.26% | -4.89% |
| 2025-11-03 | Q3 2025 | 0.27 | 0.28 | +3.70% | $3.76B | ✅ Beat | +12.32% | +17.49% | +18.82% |
| 2025-08-07 | Q2 2025 | 0.28 | 0.29 | +3.57% | $3.84B | ✅ Beat | +1.50% | +2.25% | -12.29% |
| 2025-02-06 | Q4 2024 | 0.26 | 0.26 | +0.00% | $3.66B | ➖ Inline | -4.52% | +2.10% | +14.05% |
| 2024-11-07 | Q3 2024 | 0.27 | 0.28 | +3.70% | $3.90B | ✅ Beat | +2.10% | +3.77% | +2.40% |
Showing last 8 quarters.